These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 8808477)

  • 1. [Vancomycin and teicoplanin: differential aspects].
    Cobo J
    Enferm Infecc Microbiol Clin; 1995 Dec; 13(10):600-10. PubMed ID: 8808477
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of glycopeptides in the treatment of infections caused by methicillin-resistant staphylococci].
    Bouza E; Rodríguez-Créixems M; Muñoz P
    Rev Clin Esp; 1997 Sep; 197 Suppl 2():52-8. PubMed ID: 9441324
    [No Abstract]   [Full Text] [Related]  

  • 3. Expression of glycopeptide-resistance gene in response to vancomycin and teicoplanin in the cardiac vegetations of rabbits infected with VanB-type Enterococcus faecalis.
    Lefort A; Arthur M; Depardieu F; Chau F; Pouzet C; Courvalin P; Fantin B
    J Infect Dis; 2004 Jan; 189(1):90-7. PubMed ID: 14702158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolerability of teicoplanin in 117 hospitalized adults with previous vancomycin-induced fever, rash, or neutropenia: a retrospective chart review.
    Hung YP; Lee NY; Chang CM; Lee HC; Wu CJ; Chen PL; Lee CC; Chung CH; Ko WC
    Clin Ther; 2009 Sep; 31(9):1977-86. PubMed ID: 19843487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Streptogramins and glycopeptides].
    Tsuji A
    Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():360-6. PubMed ID: 17455646
    [No Abstract]   [Full Text] [Related]  

  • 6. [Enterococcal endocarditis, a model of therapeutic difficulty].
    Fernández Guerrero ML; Núñez García A
    Rev Clin Esp; 1995 Oct; 195 Suppl 4():41-5. PubMed ID: 9441316
    [No Abstract]   [Full Text] [Related]  

  • 7. Teicoplanin in the therapy of gram-positive infections: an open non-randomized study.
    De Lalla F; Rinaldi E; Santoro D; Rizzardini G; Martello P; Guaglianone MH
    J Chemother; 1989 Jul; 1(4 Suppl):719-21. PubMed ID: 16312606
    [No Abstract]   [Full Text] [Related]  

  • 8. Health economics assessment study of teicoplanin versus vancomycin in Gram-positive infections.
    Portolés A; Palau E; Puerro M; Vargas E; Picazo JJ
    Rev Esp Quimioter; 2006 Mar; 19(1):65-75. PubMed ID: 16688294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Teicoplanin.
    Salaria M
    Indian Pediatr; 2001 Apr; 38(4):372-5. PubMed ID: 11313506
    [No Abstract]   [Full Text] [Related]  

  • 10. Absence of "red man syndrome" in patients being treated with vancomycin or high-dose teicoplanin.
    Rybak MJ; Bailey EM; Warbasse LH
    Antimicrob Agents Chemother; 1992 Jun; 36(6):1204-7. PubMed ID: 1384423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Glycopeptides (vancomycin, teicoplanin)--their place in the antibacterial therapy of patients in a high-risk group].
    Beloborodova NV
    Anesteziol Reanimatol; 1998; (4):23-7. PubMed ID: 9770813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of daptomycin in the treatment of experimental endocarditis due to susceptible and multidrug-resistant enterococci.
    Vouillamoz J; Moreillon P; Giddey M; Entenza JM
    J Antimicrob Chemother; 2006 Dec; 58(6):1208-14. PubMed ID: 17030515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacological considerations in the economic evaluation of glycopeptides].
    García-Quetglas E; Sádaba B; Honorato J
    Rev Clin Esp; 1997 Sep; 197 Suppl 2():68-73. PubMed ID: 9441326
    [No Abstract]   [Full Text] [Related]  

  • 14. Vascular graft infection by Staphylococcus aureus: efficacy of cefazolin, teicoplanin and vancomycin prophylaxis protocols in a rat model.
    Atahan E; Gul M; Ergun Y; Eroglu E
    Eur J Vasc Endovasc Surg; 2007 Aug; 34(2):182-7. PubMed ID: 17481929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Teicoplanin. New treatment potentials for gram-positive infections in the hospital].
    Iakovlev SV
    Antibiot Khimioter; 1999; 44(2):3-7. PubMed ID: 10202550
    [No Abstract]   [Full Text] [Related]  

  • 16. [Enterococcal resistance to glycopeptide antibiotics].
    Cercendado Mansilla E
    Rev Clin Esp; 1995 Oct; 195 Suppl 4():22-7. PubMed ID: 9441312
    [No Abstract]   [Full Text] [Related]  

  • 17. [Enterococcus faecalis endocarditis successfully treated with daptomycin].
    Bonnet E
    Med Mal Infect; 2008 Dec; 38 Spec No 2():4-6. PubMed ID: 19185201
    [No Abstract]   [Full Text] [Related]  

  • 18. [Glycopeptide resistant enterococci. Occurrence, distribution, resistance transmission, significance].
    Klare I; Witte W
    Wien Klin Wochenschr; 1997 May; 109(9):293-300. PubMed ID: 9265387
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapy of resistant gram-positive infection: value of glycopeptide antibiotics vancomycin and teicoplanin].
    Waldvogel F
    Schweiz Med Wochenschr; 1993 Dec; 123(50):2353-6. PubMed ID: 8272810
    [No Abstract]   [Full Text] [Related]  

  • 20. Dalbavancin: a review for dermatologists.
    Scheinfeld N
    Dermatol Online J; 2006 May; 12(4):6. PubMed ID: 17083861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.